US 12116635
Methods for detecting and treating cancers having adenosine pathway activation
granted A61KA61K2039/505A61K31/519
Quick answer
US patent 12116635 (Methods for detecting and treating cancers having adenosine pathway activation) held by Corvus Pharmaceuticals, Inc. expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K31/519, A61K45/06, A61P